Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01287026 · ClinicalTrials.gov registry record · Phase 1

Real-time MRI Right Heart Catheterization Using Passive Catheters

A Phase 1 study, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

Completed
Registry status
Phase 1
Development phase
150
Enrollment target

NCT01287026 is a Phase 1 study that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 150 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01287026, a Phase 1 study, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

COMPLETED
Registry status
Phase 1
Development phase
150 participants
Enrollment target

Study Summary

Background: \- Currently, heart catheterization procedures are guided by X-rays. Researchers are developing new techniques to perform heart catheterization without the use of X-rays by investigating possible uses of magnetic resonance imaging (MRI) scans. To study these uses, researchers are interested in performing a part of the standard X-ray catheterization procedure using MRI on individuals who are scheduled to have heart catheterization. Objectives: \- To examine the safety and feasibility of right-heart catheterization using MRI-guided catheters. Eligibility: \- Individuals at least 21 years of age who are undergoing a medically necessary heart catheterization procedure. Design: * The research MRI procedure will be performed either before or after standard X-ray guided heart catheterization. * Participants will be transferred from an X-ray table onto an MRI table and advanced into the scanner. Under MRI guidance, a MRI-compatible catheter will be used to measure blood pressure and blood oxygen levels in the heart, and MRI scanning will be performed for approximately 30 minutes.

Interventions

  • PROCEDURE Cardiac Real-time MRI RHC (Right Heart Catheterization)

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2011-02-23
Est. Completion 2019-03-21
Phase Phase 1

What the Registry Record Tells You About NCT01287026

The ClinicalTrials.gov registry entry for NCT01287026 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Cardiac Real-time MRI RHC (Right Heart Catheterization) is the first listed.

NCT01287026 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01287026 about?

NCT01287026 is a clinical study titled "Real-time MRI Right Heart Catheterization Using Passive Catheters". Background: \- Currently, heart catheterization procedures are guided by X-rays. Researchers are developing new techniques to perform heart catheterization without the use of X-rays by investigating possible uses of magnetic resonance imaging (MRI) scans. To study these uses, researchers are intere...

What is the current status of trial NCT01287026?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 150 participants. The study started on 2011-02-23. Estimated completion is 2019-03-21.

What interventions are being tested in trial NCT01287026?

The interventions under investigation include: Cardiac Real-time MRI RHC (Right Heart Catheterization) (PROCEDURE).

Who is sponsoring clinical trial NCT01287026?

This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.